Diabetes Disparities: Texting to Extend Treatment (DD-TXT)
該当なし
完了
NCT04227379
| 対象疾患 | Diabetes Mellitus, Type 2 |
|---|
| 相 | 該当なし |
|---|
| スポンサー | VA Office of Research and Development |
|---|
| ステータス | 完了 |
|---|
| 参加者数 | 366 名 |
|---|
| 介入(薬剤) | Intervention 1- DSMS+, Comparison - DSMS |
|---|
| 開始日 | 2023年1月30日 |
|---|
| 完了日 | 2025年4月30日 |
|---|
| 結果公開日 | 2026年6月1日 |
|---|
概要
One way to help Veterans improve their diabetes control is through the use of technology to help provide information, motivation, and reminders necessary to support diabetes self-management. The study will seek input from diverse groups of Veterans living with diabetes to help develop a new customizable, interactive texting intervention that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie for Veterans", a VA texting system for self-management support. Patients will be randomized to receive a once-daily standard diabetes self-management texting intervention called DSMS based on standard diabetes self-management education content or a customizable, patient-centered diabetes self-management support intervention with additional features called DSMS Plus (DSMS+) in order to test the comparative effectiveness of these two texting interventions.
Change in HbA1c Percent Time in Control
pre-enrollment, 6 month follow up · percent (%) of time in control
| DSMS | 23.41 ± 34.96 percent (%) of time in control |
|---|
| DSMS+ (DSMS Plus) | 21.61 ± 40.55 percent (%) of time in control |
|---|
| p-value | .6519 |
| Mean Difference (Net) | 1.80 (95% CI -6.05–9.65) |
Change in HbA1c
pre-enrollment, 6 month follow-up · Percentage of glycosylated hemoglobin
| DSMS | -0.36 ± 1.37 Percentage of glycosylated hemoglobin |
|---|
| DSMS+ (DSMS Plus) | -0.40 ± 1.29 Percentage of glycosylated hemoglobin |
|---|
| p-value | .7552 |
| Mean Difference (Net) | .05 (95% CI -.25–.34) |
BENITIONS で見る
ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
すべての治験
このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。